Larson Financial Group’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.8K Buy
166
+13
+8% +$1.35K ﹤0.01% 2105
2026
Q1
$14.8K Buy
153
+42
+38% +$4.31K ﹤0.01% 2013
2025
Q4
$11.8K Sell
111
-3
-3% -$348 ﹤0.01% 2023
2025
Q3
$14.5K Buy
114
+102
+850% +$12.1K ﹤0.01% 1817
2025
Q2
$1.47K Buy
+12
New +$1.37K ﹤0.01% 2521
2025
Q1
Sell
-12
Closed -$1.11K 3107
2024
Q4
$1.11K Buy
12
+11
+1,100% +$1.08K ﹤0.01% 2019
2024
Q3
$97 Buy
+1
New +$90 ﹤0.01% 2540
2021
Q2
Sell
-13
Closed -$1K 844
2021
Q1
$1K Hold
13
﹤0.01% 760
2020
Q4
$1K Hold
13
﹤0.01% 685
2020
Q3
$1K Hold
13
﹤0.01% 651
2020
Q2
$1K Hold
13
﹤0.01% 609
2020
Q1
$1K Buy
13
+5
+63% +$288 ﹤0.01% 469
2019
Q4
$0 Hold
8
﹤0.01% 594
2019
Q3
$0 Hold
8
﹤0.01% 556
2019
Q2
$0 Hold
8
﹤0.01% 509
2019
Q1
$0 Sell
8
-7
-47% -$355 ﹤0.01% 502
2018
Q4
$1K Buy
+15
New +$853 ﹤0.01% 402

Other funds holding EHC

Larson Financial Group's EHC Position: Q2 2026 in Review

Larson Financial Group increased its Encompass Health (EHC) stake by 8.5% in Q2 2026, buying an estimated $1.35K and bringing the position to 166 shares worth $16.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2105.

Larson Financial Group first reported a position in EHC in Q4 2018 and has held it in 17 quarters since. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Larson Financial Group held 166 shares of Encompass Health worth $16.8K as of Q2 2026.
  • Larson Financial Group bought 13 Encompass Health shares in Q2 2026, an estimated $1.35K.
  • Encompass Health made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2105 holding.
  • Larson Financial Group first reported a position in Encompass Health in Q4 2018 and has held it in 17 quarters since.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.